AQP5 and acute lung injury: Niclosamide was found to upregulate AQP5 expression, which could be beneficial in pathologies with reduced AQP5 levels such as acute lung injury [150], while methazolamide was reported to reduce AQP5 expression, with an impact on the migration of immune cells [151].